Akèy › Metiyè › Chemists › Irvine, CA
Chemists nan Irvine, CA: Salè H-1B
35 aplikasyon kondisyon travay pou okipasyon sa a ak yon sit travay nan Irvine, CA. Salè baz medyàn ofri $93,142; mwatye mitan $75,275–$101,900.
Demann (LCA)35
Salè medyan ofri$93,142
Mwatye salè yo$75,275–$101,900
10yèm–90yèm pousantaj$66,460–$126,540
Pa nivo salè
| Nivo revni | Salè medyan |
|---|---|
| Nivo I (antre) | $61,000 |
| Nivo II (kalifye) | $98,500 |
| Nivo III (eksperyans) | $93,142 |
| Nivo IV (plen kompetans) | $135,500 |
Depatman Travay la etabli kat nivo salè prevanlan pou chak okipasyon ak zòn, soti nan Nivo I (antre) rive nan Nivo IV (plen kompetans). Anplwayè a chwazi nivo ki koresponn ak kondisyon travay la.
Anplwayè yo
| Anplwayè | LCA | Salè medyan |
|---|---|---|
| University of California, Irvine | 10 | $74,569 |
| Bioduro LLC | 7 | $97,000 |
| Edwards Lifesciences LLC | 3 | $96,762 |
| Henkel Corporation | 2 | $84,208 |
| AbbVie Inc. | 2 | $135,500 |
| LGM Pharma Solutions | 2 | $90,000 |
| CytoChip Inc | 1 | $90,000 |
| Amica Software Inc. | 1 | $54,000 |
| Scientific Horizons Consulting LLC | 1 | $180,000 |
| Willow Laboratories, Inc. | 1 | $100,000 |
| SDC Technologies, Inc. | 1 | $111,093 |
| LGM Pharma | 1 | $75,005 |
| InnoCyto Inc | 1 | $61,000 |
| Project Chemistry, Inc. | 1 | $100,000 |
| Forma Life Sciences, Inc. | 1 | $116,699 |
Tit travay
- Postdoctoral Scholar4
- Assistant Project Scientist3
- Associate Specialist2
- Scientist I, Formulation Development2
- Senior Scientist I , Drug Delivery and Biomaterials2
- Senior R&D Chemist2
- Specialist1
- Senior Chemist1
- Scientist III, Formulation Development1
- Senior Scientist I, Quality Control1
- Microfluidic Engineer1
- Chemist1
- Senior Associate III, QA1
- Sr. Scientist, Research1
- Sr. Chemist1
Salè yo se fen ki pi ba nan salè yo ofri sou chak aplikasyon, konvèti nan yon montan anyèl; estatistik yo itilize sèlman aplikasyon tan plen sètifye. Yon LCA pa yon apwobasyon visa epi yon sèl LCA ka kouvri plizyè pozisyon. Sous: Depatman Travay Etazini, Done Divulgasyon LCA OFLC, ane fiskal 2023–2026 (dènye desizyon Jun 30, 2026).